Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 12 2022
Historique:
received: 21 09 2022
accepted: 16 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 28 12 2022
Statut: epublish

Résumé

The clinical course of IBD, characterized by relapses and remissions, is difficult to predict. Initial diagnosis can be challenging, and novel disease markers are needed. Keratin 7 (K7) is a cytoskeletal intermediate filament protein not expressed in the colonic epithelium but has been reported in IBD-associated colorectal tumors. Our aim was to analyze whether K7 is expressed in chronic colonic inflammatory diseases and evaluate its potential as a novel biomarker. K7 was analyzed in two patient cohorts using immunohistochemistry-stained colon samples and single-cell quantitative digital pathology methods. K7 was correlated to pathological changes and clinical patient characteristics. Our data shows that K7 is expressed de novo in the colonic epithelium of ulcerative colitis and Crohn's disease IBD patients, but not in collagenous or lymphocytic colitis. K7 mRNA expression was significantly increased in colons of IBD patients compared to controls when assessed in publicly available datasets. While K7 increased in areas with inflammatory activity, it was not expressed in specific crypt compartments and did not correlate with neutrophils or stool calprotectin. K7 was increased in areas proximal to pathological alterations and was most pronounced in drug-resistant ulcerative colitis. In conclusion, colonic epithelial K7 is neo-expressed selectively in IBD patients and could be investigated for its potential as a disease biomarker.

Identifiants

pubmed: 36564440
doi: 10.1038/s41598-022-26603-2
pii: 10.1038/s41598-022-26603-2
pmc: PMC9789078
doi:

Substances chimiques

Biomarkers 0
Keratin-7 0
KRT7 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22213

Informations de copyright

© 2022. The Author(s).

Références

Cell Mol Life Sci. 2021 Dec 24;79(1):10
pubmed: 34951664
Dig Dis. 2021;39(3):190-203
pubmed: 32942275
Histopathology. 2002 Jul;41(1):50-5
pubmed: 12121237
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7
pubmed: 15075390
Gastroenterology. 2012 Aug;143(2):382-9
pubmed: 22609382
Int J Biochem Cell Biol. 2020 Dec;129:105878
pubmed: 33152513
Acta Radiol. 2021 Jul;62(7):851-857
pubmed: 32722966
APMIS. 2007 Nov;115(11):1219-26
pubmed: 18092953
Mol Biol Rep. 2014 Dec;41(12):7729-35
pubmed: 25156534
Acta Histochem. 1991;91(1):21-3
pubmed: 1724863
J Pathol. 1998 Mar;184(3):234-9
pubmed: 9614373
Trends Cell Biol. 2010 Feb;20(2):79-91
pubmed: 20045331
J Pathol. 1991 Oct;165(2):145-52
pubmed: 1720817
J Cell Sci. 2004 Apr 1;117(Pt 9):1709-19
pubmed: 15075232
Gut. 2009 Dec;58(12):1612-9
pubmed: 19700435
Biomed Pharmacother. 2019 Oct;118:109228
pubmed: 31351430
Lancet. 2020 Jan 11;395(10218):123-131
pubmed: 31929014
Clin Gastroenterol Hepatol. 2020 Jan;18(1):14-23
pubmed: 31301452
Virchows Arch. 2006 Jun;448(6):756-62
pubmed: 16609910
Genome Biol. 2009;10(11):R130
pubmed: 19919682
Virchows Arch. 2001 Oct;439(4):512-22
pubmed: 11710638
Cell. 2010 Mar 19;140(6):859-70
pubmed: 20303876
Am J Pathol. 1992 Feb;140(2):427-47
pubmed: 1371204
Histopathology. 2011 Aug;59(2):225-34
pubmed: 21884201
Eur J Cell Biol. 2005 Aug;84(8):709-18
pubmed: 16180309
Nat Rev Gastroenterol Hepatol. 2016 Jan;13(1):13-27
pubmed: 26627550
Sci Rep. 2021 Sep 9;11(1):17863
pubmed: 34504224
Genet Test Mol Biomarkers. 2010 Oct;14(5):703-8
pubmed: 20854102
Ann Palliat Med. 2021 Sep;10(9):9544-9552
pubmed: 34628880
Int J Mol Sci. 2021 Jul 21;22(15):
pubmed: 34360548
BMJ Open Gastroenterol. 2015 May 18;2(1):e000024
pubmed: 26462276
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Virchows Arch. 2021 Oct;479(4):815-824
pubmed: 34312700
World J Gastroenterol. 2021 Apr 28;27(16):1828-1840
pubmed: 33967560
Clin Transl Gastroenterol. 2019 Sep;10(9):e00071
pubmed: 31478957
BMJ Open. 2019 Mar 8;9(3):e027428
pubmed: 30852550
Dis Markers. 2008;25(1):1-16
pubmed: 18776587
BMC Cancer. 2009 Oct 22;9:376
pubmed: 19849844
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):
pubmed: 33762306
Cells. 2016 Sep 10;5(3):
pubmed: 27626448
Biosci Rep. 2019 Aug 13;39(8):
pubmed: 31345960
J Crohns Colitis. 2022 Jan 28;16(1):162-165
pubmed: 34240137
Cell. 1982 Nov;31(1):11-24
pubmed: 6186379
Histochem Cell Biol. 2008 Jun;129(6):705-33
pubmed: 18461349
J Crohns Colitis. 2013 Nov;7(10):827-51
pubmed: 23870728
Dig Liver Dis. 2019 Dec;51(12):1646-1651
pubmed: 31383457
Lancet Oncol. 2008 Jun;9(6):596-9
pubmed: 18510991
Subcell Biochem. 2017;82:171-230
pubmed: 28101863
Kidney Int. 2016 Apr;89(4):792-808
pubmed: 26924053
Am J Gastroenterol. 2015 Feb;110(2):265-76; quiz 277
pubmed: 25623658
PLoS One. 2013 May 31;8(5):e64404
pubmed: 23741325

Auteurs

Lauri Polari (L)

Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University, BioCity, Tykistökatu 6A, 20520, Turku, Finland. lauri.polari@abo.fi.
InFLAMES Research Flagship Center, Åbo Akademi University, BioCity, Tykistökatu 6A, 20520, Turku, Finland. lauri.polari@abo.fi.

Mervi Tenhami (M)

Department of Clinical Medicine, University of Turku, Turku, Finland.
Division of Digestive Surgery, Turku University Hospital, Turku, Finland.

Santeri Anttila (S)

Institute of Biomedicine, University of Turku, Turku, Finland.

Terhi Helenius (T)

Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University, BioCity, Tykistökatu 6A, 20520, Turku, Finland.

Harry Kujari (H)

Laboratory Division, Turku University Hospital, Turku, Finland.

Markku Kallajoki (M)

Institute of Biomedicine, University of Turku, Turku, Finland.
Laboratory Division, Turku University Hospital, Turku, Finland.

Markku Voutilainen (M)

Department of Clinical Medicine, University of Turku, Turku, Finland.
Division of Digestive Surgery, Turku University Hospital, Turku, Finland.

Diana M Toivola (DM)

Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University, BioCity, Tykistökatu 6A, 20520, Turku, Finland. diana.toivola@abo.fi.
InFLAMES Research Flagship Center, Åbo Akademi University, BioCity, Tykistökatu 6A, 20520, Turku, Finland. diana.toivola@abo.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH